Pfizer's vaccine was found to 88 per cent effective against symptomatic disease from the Indian variant two weeks after the second dose. AFP
Pfizer's vaccine was found to 88 per cent effective against symptomatic disease from the Indian variant two weeks after the second dose. AFP
Covid vaccines work well against Indian variant
New research finds a double dose of either Pfizer-BioNTech or AstraZeneca offers significant protection
